TWD 330.5
(1.85%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 365.09 Million TWD | -38.74% |
2022 | 595.98 Million TWD | 137.35% |
2021 | 251.1 Million TWD | 217.43% |
2020 | 79.1 Million TWD | 36.05% |
2019 | 58.14 Million TWD | -88.07% |
2018 | 487.5 Million TWD | 951.21% |
2017 | 46.37 Million TWD | -59.67% |
2016 | 115 Million TWD | -34.19% |
2015 | 174.75 Million TWD | 1.92% |
2014 | 171.45 Million TWD | -14.95% |
2013 | 201.59 Million TWD | 17.58% |
2012 | 171.45 Million TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 470.73 Million TWD | 28.94% |
2024 Q3 | 515 Million TWD | 9.81% |
2024 Q2 | 469.01 Million TWD | -0.37% |
2023 Q3 | 406.55 Million TWD | -3.77% |
2023 Q4 | 365.09 Million TWD | -10.2% |
2023 Q1 | 456.47 Million TWD | -23.41% |
2023 FY | 365.09 Million TWD | -38.74% |
2023 Q2 | 422.48 Million TWD | -7.45% |
2022 Q4 | 595.98 Million TWD | -6.54% |
2022 Q1 | 246.81 Million TWD | -1.7% |
2022 Q2 | 668.72 Million TWD | 170.94% |
2022 FY | 595.98 Million TWD | 137.35% |
2022 Q3 | 637.69 Million TWD | -4.64% |
2021 Q2 | 129.5 Million TWD | 52.22% |
2021 Q1 | 85.07 Million TWD | 7.55% |
2021 Q3 | 245.89 Million TWD | 89.87% |
2021 Q4 | 251.1 Million TWD | 2.12% |
2021 FY | 251.1 Million TWD | 217.43% |
2020 FY | 79.1 Million TWD | 36.05% |
2020 Q4 | 79.1 Million TWD | -0.94% |
2020 Q1 | 65.25 Million TWD | 12.23% |
2020 Q2 | 62 Million TWD | -4.97% |
2020 Q3 | 79.85 Million TWD | 28.79% |
2019 Q1 | - TWD | -100.0% |
2019 FY | 58.14 Million TWD | -88.07% |
2019 Q4 | 58.14 Million TWD | -95.04% |
2019 Q3 | 1.17 Billion TWD | -6.03% |
2019 Q2 | 1.24 Billion TWD | 0.0% |
2018 Q2 | 697 Million TWD | 0.0% |
2018 Q1 | - TWD | -100.0% |
2018 FY | 487.5 Million TWD | 951.21% |
2018 Q4 | 487.5 Million TWD | 0.0% |
2017 Q1 | 71.5 Million TWD | -37.83% |
2017 FY | 46.37 Million TWD | -59.67% |
2017 Q3 | 46.37 Million TWD | -35.14% |
2017 Q2 | 71.5 Million TWD | 0.0% |
2017 Q4 | 46.37 Million TWD | 0.0% |
2016 FY | 115 Million TWD | -34.19% |
2016 Q4 | 115 Million TWD | 0.0% |
2016 Q3 | 115 Million TWD | -18.15% |
2016 Q1 | 140.5 Million TWD | -19.6% |
2016 Q2 | 140.5 Million TWD | 0.0% |
2015 Q4 | 174.75 Million TWD | 0.0% |
2015 Q2 | 122.15 Million TWD | 0.0% |
2015 FY | 174.75 Million TWD | 1.92% |
2015 Q3 | 174.75 Million TWD | 43.06% |
2015 Q1 | 122.15 Million TWD | -28.76% |
2014 Q1 | 223.71 Million TWD | 10.98% |
2014 Q2 | 223.71 Million TWD | 0.0% |
2014 Q3 | 171.45 Million TWD | -23.36% |
2014 Q4 | 171.45 Million TWD | 0.0% |
2014 FY | 171.45 Million TWD | -14.95% |
2013 Q4 | 201.59 Million TWD | 0.0% |
2013 Q1 | - TWD | 0.0% |
2013 FY | 201.59 Million TWD | 17.58% |
2013 Q3 | 201.59 Million TWD | 0.0% |
2012 FY | 171.45 Million TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Nang Kuang Pharmaceutical Co., Ltd. | 12.56 Million TWD | -2805.164% |
Maxigen Biotech Inc. | - TWD | -Infinity% |
SciVision Biotech Inc. | 346.69 Million TWD | -5.306% |
Bionime Corporation | 1.69 Billion TWD | 78.49% |
Visco Vision Inc. | 848.86 Million TWD | 56.991% |